Methods and systems for processing polynucleotides

US9701998B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9701998-B2
Application numberUS-201615376582-A
CountryUS
Kind codeB2
Filing dateDec 12, 2016
Priority dateDec 14, 2012
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of nucleic acid sequence analysis, comprising: (a) providing a plurality of partitions comprising a plurality of polynucleotide molecules and a plurality of barcode molecules, wherein: i. said plurality of partitions comprises at least 1,000 partitions; ii. said plurality of barcode molecules comprises at least 1,000 different nucleic acid barcode molecules having different barcode sequences; iii. said at least 1,000 different nucleic acid barcode molecules are disposed within separate partitions of said at least 1,000 partitions, such that each of said at least 1,000 partitions has a different barcode sequence of said different barcode sequences; and iv. said at least 1,000 partitions are at least 1% of said plurality of partitions; (b) subsequent to (a), generating a plurality of barcoded molecules from said plurality of polynucleotide molecules and said plurality of barcode molecules within said plurality of partitions; and (c) directing said plurality of barcoded molecules generated in (b) to nucleic acid sequencing, wherein a sequence of a given polynucleotide of said plurality of polynucleotide molecules is determined. 2. The method of claim 1 , wherein said plurality of partitions is a plurality of droplets. 3. The method of claim 1 , wherein a given partition of said at least 1,000 partitions comprises at least 1,000 nucleic acid barcode molecules, which at least 1,000 nucleic acid barcode molecules have a common barcode sequence from a given one of said at least 1,000 different nucleic acid barcode molecules. 4. The method of claim 3 , wherein a given partition of said at least 1,000 partitions comprises at least 20,000 nucleic acid barcode molecules, which at least 20,000 nucleic acid barcode molecules have a common barcode sequence from a given one of said at least 1,000 different nucleic acid barcode molecules. 5. The method of claim 1 , wherein said plurality of barcode molecules are coupled to beads. 6. The method of claim 5 , wherein said beads are gel beads. 7. The method of claim 5 , where each of said beads comprises a bond that is cleavable upon application of a stimulus. 8. The method of claim 5 , further comprising exposing said beads to a stimulus to release said plurality of barcode molecules. 9. The method of claim 8 , wherein said stimulus is a chemical stimulus. 10. The method of claim 1 , further comprising, subsequent to (b), subjecting said plurality of barcoded molecules to release from said plurality of partitions. 11. The method of claim 1 , further comprising, prior to (c), subjecting said plurality of barcoded molecules to nucleic acid amplification. 12. The method of claim 1 , wherein at least one partition of said plurality of partitions does not include a barcode molecule. 13. The method of claim 1 , wherein a given partition of said at least 1,000 partitions comprises multiple copies of a given barcode molecule of said plurality of barcode molecules. 14. The method of claim 1 , wherein said at least 1,000 partitions are at least 50% of said plurality of partitions. 15. The method of claim 1 , wherein said plurality of barcode molecules comprises at least 10,000 different nucleic acid barcode molecules. 16. The method of claim 1 , wherein said plurality of barcode molecules comprises at least 100,000 different nucleic acid barcode molecules. 17. The method of claim 1 , wherein said plurality of partitions comprises at least 5,000 partitions. 18. The method of claim 1 , wherein said plurality of partitions includes reagents necessary for nucleic acid amplification. 19. The method of claim 1 , further comprising fragmenting a nucleic acid molecule into said plurality of polynucleotide molecules. 20. The method of claim 19 , wherein (c) comprises subjecting said plurality of barcoded molecules or derivatives thereof to nucleic acid sequencing, thereby determining a sequence of said nucleic acid molecule. 21. The method of claim 1 , wherein said plurality of partitions is a plurality of wells. 22. The method of claim 1 , wherein said at least 1,000 partitions are at least 10% of said plurality of partitions. 23. The method of claim 1 , wherein said at least 1,000 partitions comprises at least 10,000 partitions, and wherein each of said at least 10,000 partitions has a different barcode sequence of said different barcode sequences. 24. The method of claim 1 , wherein said at least 1,000 partitions comprises at least 100,000 partitions, and wherein each of said at least 100,000 partitions has a different barcode sequence of said different barcode sequences. 25. The method of claim 1 , wherein a given partition of said at least 1,000 partitions comprises at least 1,000 nucleic acid barcode molecules. 26. The method of claim 25 , wherein said given partition of said at least 1,000 partitions comprises at least 10,000 nucleic acid barcode molecules. 27. The method of claim 26 , wherein said given partition of said at least 1,000 partitions comprises at least 100,000 nucleic acid barcode molecules. 28. The method of claim 27 , wherein said given partition of said at least 1,000 partitions comprises at least 1,000,000 nucleic acid barcode molecules. 29. The method of claim 1 , wherein a given partition of said at least 1,000 partitions is a droplet in an emulsion, and wherein said droplet comprises a bead associated with a given one of said at least 1,000 different nucleic acid barcode molecules. 30. The method of claim 1 , wherein a given partition of said at least 1,000 partitions is a well, and wherein said well comprises a surface associated with a given one of said at least 1,000 different nucleic acid barcode molecules. 31. The method of claim 1 , wherein a given partition of said at least 1,000 partitions is a capsule, and wherein said capsule comprises a surface associated with a given one of said at least 1,000 different nucleic acid barcode molecules. 32. The method of claim 7 , wherein said bond is a disulfide bond. 33. The method of claim 7 , wherein said bond is a peptide bond. 34. The method of claim 9 , wherein said chemical stimulus comprises a reducing agent. 35. The method of claim 8 , wherein, for a given partition of said at least 1,000 partitions, said stimulus comprises an agent disposed in said given partition. 36. The method of claim 8 , wherein said stimulus initiates depolymerization of a component of said bead. 37. The method of claim 8 , wherein said stimulus is selected from the group consisting of a change in pH, an osmotic trigger and a change in ion concentration. 38. The method of claim 5 , wherein said beads comprise cross-linked polymers. 39. The method of claim 1 , wherein a given one of said plurality of barcode molecules comprises a priming sequence. 40. The method of claim 1 , wherein said at least 1,000 partitions do not contain components necessary for polymerase chain reaction (PCR). 41. The method of claim 1 , further comprising determining polynucleotide phasing. 42. The method of claim 1 , further comprising detection of linked genetic variations present in said plurality of

Assignees

Inventors

Classifications

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Methods for sequencing · CPC title

  • Ligating adaptors · CPC title

  • the label being a nucleic acid · CPC title

  • Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9701998B2 cover?
The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.
Who is the assignee on this patent?
10X Genomics Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).